(GKOS) |
| 0 (0%) 10-11 07:55 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 185.35 |
| Resistance 1: | 170.47 |
| Pivot price: | 161.14 |
| Support 1: | 146.38 |
| Support 2: | 121.79 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -3.260 |
| Book Value | 11.600 |
| PEG Ratio | 0.00 |
| Gross Profit | 8.221 |
| Profit Margin (%) | -30.68 |
| Operating Margin (%) | -8.50 |
| Return on Assets (ttm) | -5.2 |
| Return on Equity (ttm) | -26.0 |
Company news
Sat, 10 Oct 2026
Glaukos Corporation (GKOS) Stock Forecasts - Yahoo! Finance Canada
Fri, 09 Oct 2026
Glaukos: The Second J-Code Rewrites The Risk Math - Seeking Alpha
Fri, 09 Oct 2026
Glaukos Corp (GKOS) Reports Positive Phase 4 Trial Results for i - GuruFocus
Fri, 09 Oct 2026
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Glaukos (GKOS) and Pfizer (PFE) - The Globe and Mail
Fri, 09 Oct 2026
Adding an eye treatment to cataract surgery lowered pressure more than surgery alone. - Stock Titan
Thu, 08 Oct 2026
A new license lets Glaukos pursue up to four more potential retinal treatments - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
